Edition:
United Kingdom

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

1.47USD
20 Apr 2018
Change (% chg)

$-0.07 (-4.55%)
Prev Close
$1.54
Open
$1.53
Day's High
$1.53
Day's Low
$1.47
Volume
4,402
Avg. Vol
29,428
52-wk High
$3.69
52-wk Low
$1.32

Select another date:

Thu, Mar 15 2018

BRIEF-Vical Reports Q4 Loss Per Share Of $0.21

* VICAL REPORTS FOURTH QUARTER 2017 FINANCIAL AND OPERATIONAL RESULTS

BRIEF-Vical Announces Restructuring To Focus Resources On Hsv-2 And Antifungal Clinical Programs

* VICAL ANNOUNCES RESTRUCTURING TO FOCUS RESOURCES ON HSV-2 AND ANTIFUNGAL CLINICAL PROGRAMS

BUZZ-Vical: Falls as herpes vaccine fails late-stage trial

** Drugmaker's shares fall 27.81 pct to $1.35 - top pct loser among Nasdaq-listed stocks premarket

BRIEF-‍Stonepine Capital Management reports 6.6 pct passive stake in Vical

* ‍Stonepine Capital Management Llc reports 6.6 percent passive stake in Vical Inc as on November 8, 2017 - SEC filing​ Source text: (http://bit.ly/2z2Y7Nh) Further company coverage:

BRIEF-Vical Incorporated announces pricing of $25 mln underwritten public offering of common stock

* Vical Incorporated announces pricing of $25 million underwritten public offering of common stock

BRIEF-VICAL ANNOUNCES JOINT DEVELOPMENT PROGRAM WITH ANGES ON TREATMENT FOR CHRONIC HEPATITIS B INFECTION

* VICAL ANNOUNCES JOINT DEVELOPMENT PROGRAM WITH ANGES ON A TREATMENT FOR CHRONIC HEPATITIS B INFECTION

BRIEF-Vical reports Q3 loss per share $0.27

* Vical reports third quarter 2017 financial and operational results

Select another date: